What's Hot

    Things to do in Las Vegas for the outdoorsy person

    March 27, 2023

    How to Get Rid of TransWorld Systems

    March 14, 2023

    The Best Trampolines of 2023

    March 14, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    News FinancialNews Financial
    Subscribe
    • Home
    • News
    • Economics News
    • Markets

      Amazon’s Whole Foods Deal Will Hit Costco

      March 1, 2023

      Nio and Li Auto Stock

      February 18, 2023

      Sema4 Holdings Stock

      February 17, 2023

      Terra Luna , LUNA Stocktwits

      February 16, 2023

      Zion Oil & Gas stock share

      February 14, 2023
    • Funds
      1. Stocks
      2. Investments
      3. View All

      How to Buy Google Stock in 2023

      March 6, 2023

      Best Skin Tag Removal in 2023 

      March 2, 2023

      B. Riley Principal 150 Merger ,BRPM Stock

      February 18, 2023

      Semrush ,Semr Stock news

      February 18, 2023

      How to Remove LJ Ross Associates

      March 6, 2023

      Carrie Jernigan donating shoes to needy ones

      March 6, 2023

      Titan Reviews : Invest , pros and cons

      February 17, 2023

      How Much Social Security Checks Are Increasing in 2023

      February 14, 2023

      The Best Vanguard Mutual Funds Active

      February 17, 2023

      Turbobaster Update | Shark Tank Season 1

      December 14, 2022

      Contribution Margin: Definition, Overview, and How To Calculate

      December 14, 2022

      What Is Residual Income?

      December 13, 2022
    • Crypto News
    • Tech
    News FinancialNews Financial
    Home » Sema4 Holdings Stock
    Markets

    Sema4 Holdings Stock

    Jacob ThomasBy Jacob ThomasFebruary 17, 2023Updated:February 17, 2023No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Sema4 announces name change to GeneDx

    Sema4 (Nasdaq: Sema4 SMFR) today announced that it is changing its brand name Sema4 Holdings Corp. To GeneDx Holdings Corp. GeneDx (Nasdaq WGS) is a leader in improving health outcomes by utilizing clinical and genomic insights that is uniquely placed to increase the utilization of large-scale genomic and clinical data to allow precision medicine to be the standard of health care.

    GeneDx’s leading exome and genomic tests are enhanced with Centrellis(r) an innovative Health Information Platform. Based on one of the largest rare-disease data sets with millions of medical data, Centrellis integrates digital tools with artificial intelligence to collect and synthesize genomic and clinical information. GeneDx is advancing greater understanding of the complex diseases than ever before. This results in faster diagnosis and more efficient treatment plans and improved discovery of drugs.

    “For over 20 years GeneDx have earned continuous trust of the world’s genetics experts while also innovating and increasing the usage of its clinically-actionable exome and genome analysis. Through combining the best features of GeneDx as well as Sema4 to sustain our growth We are at the crossroads between data and diagnostics, combining years of experience in genomic interpretation with the unrivaled capability to analyze data from clinical studies at a scale. GeneDx now has the ability to bring together powerful genomic information together with clinical data to enhance the quality of healthcare for individuals and groups,” said Katherine Stueland the CEO and President of GeneDx.

    Alongside changing the company’s name, the classes of Class A common stock will be traded with the ticker symbol “WGS,” in recognition of the role that the company played in the pioneering of Whole Genome Sequencing (WGS). The company anticipates that the shares in Class A stock to start trading on the NASDAQ Stock Market under the new name and ticker symbol on January 10, 2023.

    What was the cause?

    Sema4 Holdings’ shares Sema4 Holdings ( SMFR -1.28 percent) were sinking 17.7 percent as of 11.36 a.m. (EDT) on Tuesday. The decrease came shortly after the company that provides genomic and clinical intelligence platform company released its results for the second quarter after the close of trading on Monday.

    So , what’s next?

    Sema4 reported Q2 revenues at $46.9 million, which was up 56% over the previous year. Sema4 reported an operating loss of $45.4 million, higher than the losses of $32.1 million during the previous period. A lot of investors were looking forward to better results, such as the huge sale.

    It’s been just a month since Sema4 was made public through an acquisition with special-purpose acquisition corporation ( SPAC) CM Life Sciences. When the merger was made public on February 1, CM Life Sciences’ board chairman Keith Meister said that Sema4’s revenues would rise between $200 and $500 million, and the gross margin would double by 2023.

    Sema4’s CFO Isaac Ro thinks that revenue goal is feasible. He said “Volume growth is strong , and we are confident in our long-term plan to generate 500 million in revenue by 2023 through partnerships with health systems, broaden the scope of our offerings and grow the company.”

    Perhaps the biggest issue for Sema4 is to increase their gross margin. Sema4 reported a loss of $2.8 million in the second quarter due to the higher cost of services.

    What do we do now?

    Sema4’s collaborations may be the primary thing to keep an eye on for the company in the next few years. Recently, Sema4 expanded its partnerships with NorthShore University HealthSystem, AdventHealth along with Avera Health.

    Sema4 Sema4 holdings news Sema4 stock forecast
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleThe Best Vanguard Mutual Funds Active
    Next Article BioXcel Therapeutics, BTAI Stock
    Jacob Thomas

    Related Posts

    Amazon’s Whole Foods Deal Will Hit Costco

    March 1, 2023

    Nio and Li Auto Stock

    February 18, 2023

    Terra Luna , LUNA Stocktwits

    February 16, 2023
    Add A Comment

    Leave A Reply Cancel Reply

    Top Posts

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    Advertisement
    Demo

    NewsFinancial.info is an online News Provider. Read lates Financial and business News.
    Contact Us- newsfinancial@yahoo.com

    Facebook Twitter Instagram Pinterest YouTube
    Top Insights
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2023 Newsfinancial.info. Designed by Digitalsxpert Service Pvt. Ltd.
    • Home
    • Privacy Policy
    • Get In Touch
    • Our Authors

    Type above and press Enter to search. Press Esc to cancel.